ILM-FENNEC UMR 5306
Lucie Sancey has not added Biography.
If you are Lucie Sancey and would like to personalize this page please email our Author Liaison for assistance.
In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
European journal of nuclear medicine and molecular imaging Dec, 2007 | Pubmed ID: 17674000
Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells.
Organic & biomolecular chemistry Jan, 2009 | Pubmed ID: 19109663
Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.
Cancer biotherapy & radiopharmaceuticals Dec, 2008 | Pubmed ID: 19111043
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
Molecular therapy : the journal of the American Society of Gene Therapy May, 2009 | Pubmed ID: 19259068
Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
Molecular therapy : the journal of the American Society of Gene Therapy Mar, 2010 | Pubmed ID: 19826406
Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.
Molecular therapy : the journal of the American Society of Gene Therapy Mar, 2010 | Pubmed ID: 19826407
In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology Jun, 2010 | Pubmed ID: 20087797
Application of click-click chemistry to the synthesis of new multivalent RGD conjugates.
Organic & biomolecular chemistry Nov, 2010 | Pubmed ID: 20835451
Targeted delivery of a proapoptotic peptide to tumors in vivo.
Journal of drug targeting Aug, 2011 | Pubmed ID: 21182462
Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells.
Journal of cell science Feb, 2011 | Pubmed ID: 21245196
The multiple roles of amphiregulin in human cancer.
Biochimica et biophysica acta Dec, 2011 | Pubmed ID: 21658434
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution.
Advanced drug delivery reviews Feb, 2012 | Pubmed ID: 21983079
Ultrasmall rigid particles as multimodal probes for medical applications.
Angewandte Chemie (International ed. in English) Dec, 2011 | Pubmed ID: 22057640
The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells.
Molecular pharmaceutics Feb, 2012 | Pubmed ID: 22142367
Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
Cancer science Jun, 2012 | Pubmed ID: 22448775
Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.
Nanomedicine : nanotechnology, biology, and medicine Apr, 2013 | Pubmed ID: 22960195
Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles.
Biomaterials Jan, 2013 | Pubmed ID: 23046756
Development of gadolinium based nanoparticles having an affinity towards melanin.
Nanoscale Feb, 2013 | Pubmed ID: 23334308
In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles.
Chemical communications (Cambridge, England) Apr, 2013 | Pubmed ID: 23467614
A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.
Chemistry (Weinheim an der Bergstrasse, Germany) May, 2013 | Pubmed ID: 23512788
Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting.
International journal of pharmaceutics Sep, 2013 | Pubmed ID: 23747436
Bifunctional polypyridyl-Ru(II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy.
Dalton transactions (Cambridge, England : 2003) Sep, 2013 | Pubmed ID: 23860731
Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
Bioconjugate chemistry Sep, 2013 | Pubmed ID: 23978076
Mn(II)-containing coordination nanoparticles as highly efficient T1 contrast agents for magnetic resonance imaging.
Chemical communications (Cambridge, England) May, 2014 | Pubmed ID: 24829060
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados